SCHEMBL1498414

SCHEMBL1498414

CN(C(=O)OC(C)(C)C)C1CCC(Sc2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SLC6A2 P23975 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ TP53 P04637 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ TAS1R3 Q7RTX0 1/20 0.36
▸ TAS1R1 Q7RTX1 1/20 0.36
▸ TAS1R2 Q8TE23 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ KCNN4 O15554 1/20 0.35
▸ LSS P48449 1/20 0.35
▸ HTR6 P50406 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ OPRL1 P41146 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1498291 0.86 POLB (0.46) POLBRAB9ASLC6A2SLC6A4SLC6A3
SCHEMBL12688441 0.80 KDM1A (0.47) POLBMEN1KMT2ATAS1R3TAS1R1
SCHEMBL12688425 0.80 KDM1A (0.47) POLBMEN1KMT2ATAS1R3TAS1R1
SCHEMBL1498428 0.79 ATM (0.38) POLBRAB9ATP53ALDH1A1KMT2A
SCHEMBL11439007 0.78 HTR2C (0.44) SLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL1498332 0.78 STS (0.49) POLBMEN1KMT2AMAPTCTSS
SCHEMBL1498496 0.78 HTR6 (0.44) POLBRAB9AHTR6
SCHEMBL12692956 0.77 ACACB (0.47) —
SCHEMBL12692954 0.77 ACACB (0.47) —
SCHEMBL1498284 0.75 NOTUM (0.49) POLBALDH1A1RXFP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011035159-A1 ARYL SULPHONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS ZALICUS PHARMACEUTICALS LTD. (CA) 2011-03-24 — — WO disclosed
Send feedback